Back to BlackRock, Inc. BlackRock, Inc.

RLMDRLMD
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Relmada Therapeutics Inc

BlackRock, Inc. holds 7.4M shares of RLMD (Relmada Therapeutics Inc), worth $51.4M as of 2026-Q2. The position was increased (+475.9% shares). RLMD represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$51.4M

Current Shares

7.4M

Total Value Change

+$51.1M

Total Shares Change

+6.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.4M
+475.9%
$51.4M0.0%$6.92
47
2026-Q1
Increased
1.3M
+1.7%
$9M0.0%$4.67
28
2025-Q4
Increased
1.3M
+149.5%
$6.1M0.0%$4.53
44
2025-Q3
Unchanged
508,000
0.0%
$1M0.0%$1.88
0
2025-Q2
Decreased
508,000
-10.4%
$304,9520.0%$0.61
0
2025-Q1
Decreased
566,905
-4.5%
$153,0640.0%$0.30
0
2024-Q4
First report
593,326
-
$308,5300.0%$0.46
0

Other major holders of RLMD: RTW INVESTMENTS, LP, Jupiter Topco LLC, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used